Significant correlations were found between KIF26B expression and four clinicopathological factors including tumor size (P = 0.011), lymph node status (P = 0.009), grade (P = 0.0017), and ER status (P = 0.012) (Table 1). This evidence concerns the gene KIF26B and neoplasm.